Cargando…
GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status
Background: GADD45α is a tumor suppressor protein often upregulated by environmental stresses and DNA-damage agents to cause growth arrest, apoptosis, tumor growth inhibition, and anti-angiogenesis. A novel suicide gene therapy vector pE9NS.G45α was engineered by cloning GADD45α opening reading fram...
Autores principales: | Shi, Qiwen, Sutariya, Vijaykumar, Varghese Gupta, Sheeba, Bhatia, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497884/ https://www.ncbi.nlm.nih.gov/pubmed/31114253 http://dx.doi.org/10.2147/OTT.S192061 |
Ejemplares similares
-
CArG-driven GADD45α activated by resveratrol inhibits lung cancer cells
por: Shi, Qiwen, et al.
Publicado: (2015) -
Sequential activation of Elk-1/Egr-1/GADD45α by arsenic
por: Shi, Qiwen, et al.
Publicado: (2014) -
Gadd45β and Gadd45γ are critical for regulating autoimmunity
por: Liu, Lin, et al.
Publicado: (2005) -
Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations
por: Gupta, Deepak, et al.
Publicado: (2018) -
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs
por: Naoum, George E., et al.
Publicado: (2017)